Boston Scientific: Reclaiming Neurovascular Dominance Through Thrombectomy Precision [Seeking Alpha]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Seeking Alpha
BSX expands into high-growth neurovascular and peripheral thrombectomy segments, leveraging PEN's 11% WAMGR pipeline and robust product suite. The acquisition is expected to be dilutive to adjusted EPS by $0.06–$0.08 in year one, then neutral or accretive thereafter. BSX's increased debt and share issuance are manageable; long-term margin and market share gains are anticipated, supporting a bullish outlook. narvo vexar/iStock via Getty Images Introduction Boston Scientific Corporation ( BSX ) is in the news this morning because it entered into a definitive agreement to acquire Penumbra PEN ) for around $14.5B in a cash and stock transaction, which This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than f
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Boston Scientific (NYSE:BSX) was given a new $115.00 price target on by analysts at National Bankshares, Inc..MarketBeat
- Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at TD Cowen.MarketBeat
- How Surging Heart-Device Demand And Margin Gains At Boston Scientific (BSX) Has Changed Its Investment Story [Yahoo! Finance]Yahoo! Finance
- Boston Scientific Reshapes Portfolio With Nalu And Penumbra Neuro Deals [Yahoo! Finance]Yahoo! Finance
- Boston Scientific Expands Neuromodulation And Obesity Trials As Valuation Stays Rich [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 10/22/25 - Beat
BSX
Sec Filings
- 1/21/26 - Form 425
- 1/15/26 - Form 8-K
- 1/15/26 - Form 8-K
- BSX's page on the SEC website